Cover Image
市場調查報告書

注射器及注射針:開發平台分析

Syringes and Needles - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 336431
出版日期 內容資訊 英文 175 Pages
訂單完成後即時交付
價格
Back to Top
注射器及注射針:開發平台分析 Syringes and Needles - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年08月23日 內容資訊: 英文 175 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的注射器及注射針之開發中產品資訊分析,提供您臨床實驗/產品開發的整體進展,及各階段·各地區·各領域的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發·資本交易的動向等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 注射器及注射針概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)

第4章 注射器及注射針:正在開發的開發中產品 (各企業)

  • 注射器及注射針的開發企業:開發中產品 (各開發階段)
  • 注射器及注射針:各開發階段的開發中產品一覽

第5章 注射器及注射針的開發企業·產品概要

  • Children's Hospital Boston
    • 開發中產品及進行中的臨床實驗概要
  • Cornell University
  • Globe Medical Tech, Inc.
  • MedPro Safety Products, Inc.
  • Micropoint Technologies Pte Ltd
  • Olberon Medical Innovation SAS
  • Protectus Medical Devices, Inc.
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Syrindicare, Inc
  • Telezon Ltd
  • Unilife Corporation
  • Universitat Politecnica de Catalunya
  • University of South Florida

第6章 注射器及注射針:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0415EPD

GlobalData's Medical Devices sector report, "Syringes and Needles - Medical Devices Pipeline Assessment, 2017" provides an overview of Syringes and Needles currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Syringes and Needles pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Syringes and Needles under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Syringes and Needles and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Syringes and Needles under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Syringes and Needles Overview 10

3 Products under Development 11

  • 3.1 Syringes and Needles - Pipeline Products by Stage of Development 11
  • 3.2 Syringes and Needles - Pipeline Products by Segment 12
  • 3.3 Syringes and Needles - Pipeline Products by Territory 13
  • 3.4 Syringes and Needles - Pipeline Products by Regulatory Path 14
  • 3.5 Syringes and Needles - Pipeline Products by Estimated Approval Date 15

4 Syringes and Needles - Pipeline Products under Development by Companies 16

  • 4.1 Syringes and Needles Companies - Pipeline Products by Stage of Development 16
  • 4.2 Syringes and Needles - Pipeline Products by Stage of Development 18

5 Syringes and Needles Companies and Product Overview 20

  • 5.1 ARTE CORPORATION Company Overview 20
    • 5.1.1 ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 Baxter International Inc Company Overview 21
    • 5.2.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Becton Dickinson and Co Company Overview 22
    • 5.3.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Cincinnati Children's Hospital Medical Center Company Overview 26
    • 5.4.1 Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.5 Daxor Corp Company Overview 28
    • 5.5.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.6 Excelsior Medical, LLC Company Overview 29
    • 5.6.1 Excelsior Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.7 Galderma SA Company Overview 30
    • 5.7.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.8 Gerresheimer AG Company Overview 31
    • 5.8.1 Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.9 Globe Medical Tech Inc Company Overview 33
    • 5.9.1 Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.10 iScience Interventional Inc Company Overview 35
    • 5.10.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.11 Medigard Limited Company Overview 36
    • 5.11.1 Medigard Limited Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.12 Olberon Medical Innovation SAS Company Overview 39
    • 5.12.1 Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.13 Owen Mumford Ltd Company Overview 40
    • 5.13.1 Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.14 Protectus Medical Devices, Inc. Company Overview 41
    • 5.14.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.15 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 42
    • 5.15.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.16 Rutgers The State University of New Jersey Company Overview 43
    • 5.16.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.17 Syrindicare, Inc Company Overview 44
    • 5.17.1 Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.18 Telezon Ltd Company Overview 45
    • 5.18.1 Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.19 Terumo Corp Company Overview 47
    • 5.19.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.20 Unilife Corporation Company Overview 48
    • 5.20.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.21 United Medical Innovations Company Overview 53
    • 5.21.1 United Medical Innovations Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.22 University of California Berkeley Company Overview 54
    • 5.22.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.23 University of Louisville Company Overview 55
    • 5.23.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.24 University of Massachusetts Amherst Company Overview 56
    • 5.24.1 University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.25 University of South Florida Company Overview 57
    • 5.25.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.26 Virginia Commonwealth University Company Overview 58
    • 5.26.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 58

6 Syringes and Needles- Recent Developments 59

  • 6.1 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 59
  • 6.2 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 60
  • 6.3 Jul 31, 2017: Analytica: Quarterly Cash Flow Report 62
  • 6.4 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 63
  • 6.5 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 63
  • 6.6 Jul 27, 2017: West Announces Second-Quarter 2017 Results 64
  • 6.7 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 66
  • 6.8 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 67
  • 6.9 Jul 14, 2017: Vitrolife: Interim report January-June 2017: Successes in Asia and in Time-lapse 69
  • 6.10 Jul 13, 2017: Gerresheimer Expecting Recovery in Second Half Year 69
  • 6.11 Jul 12, 2017: Pinnacle Spine Group Issued Newest Patent for In Situ Graft Delivery to a Fusion Device 70
  • 6.12 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 71
  • 6.13 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 72
  • 6.14 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 72
  • 6.15 Jun 14, 2017: Clinical trials of Injeq IQ-Needle to expand in the Nordic countries 74
  • 6.16 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 74
  • 6.17 Jun 09, 2017: Chief Financial Officer leaves Vigmed 75
  • 6.18 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer 75
  • 6.19 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 75
  • 6.20 Jun 06, 2017: BD Releases 2016 Sustainability Report 76
  • 6.21 Jun 01, 2017: West Elects New Director to the Board 76
  • 6.22 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 77
  • 6.23 May 31, 2017: Daxor Announces Hiring of Chief Financial Officer 78
  • 6.24 May 30, 2017: Interim Report Vigmed Holding 1 January - 31 March 2017 78
  • 6.25 May 26, 2017: Merit Medical Announces Appointment of New Director 79
  • 6.26 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 79
  • 6.27 May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director 82
  • 6.28 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 83
  • 6.29 May 02, 2017: Medline Names New President of Canadian Business 85
  • 6.30 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 86
  • 6.31 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 87
  • 6.32 Apr 27, 2017: West Announces First-Quarter 2017 Results 87
  • 6.33 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 89
  • 6.34 Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results 90
  • 6.35 Apr 25, 2017: Vitrolife: Interim report January - March 2017: Good growth in all regions 91
  • 6.36 Apr 24, 2017: AMI Announces Formation of Sidoris Biomedical to Advance the Commercialization of Devices Created from Proprietary Bioresorbable Metal 91
  • 6.37 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 92
  • 6.38 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 92
  • 6.39 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 93
  • 6.40 Apr 12, 2017: Unilife Files for Chapter 11 Protection 93
  • 6.41 Apr 03, 2017: Retractable Technologies Reports Results for the Year 2016 94
  • 6.42 Mar 31, 2017: B. Braun continues its sales and earnings growth 95
  • 6.43 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 97
  • 6.44 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 97
  • 6.45 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 97
  • 6.46 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 98
  • 6.47 Mar 06, 2017: Medline Announces New Chief Marketing Officer 99
  • 6.48 Feb 28, 2017: Pyng Medical Reports First Quarter Fiscal 2017 Results 99
  • 6.49 Feb 28, 2017: Myoderm Opens Brand New UK Clinical Distribution Facility 100
  • 6.50 Feb 27, 2017: Year-End Report Vigmed Holding: January - December 2016 100
  • 6.51 Feb 22, 2017: Change in the B. Braun Management Board 101
  • 6.52 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 101
  • 6.53 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 104
  • 6.54 Feb 16, 2017: Baxter Debuts Enteral Nutrition ENFit Syringe and Accesory Line During Clinical Nutrition Week 2017 105
  • 6.55 Feb 16, 2017: West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend 106
  • 6.56 Feb 15, 2017: Gerresheimer Delivers Sustained Profitability Growth in 2016 and Proposes a Dividend Increase of 23.5% 110
  • 6.57 Feb 09, 2017: Vitrolife: Report On Operations 2016: Strong Growth And Strengthened Income 111
  • 6.58 Feb 09, 2017: Terumo Announces Change of Executive Officers 112
  • 6.59 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 113
  • 6.60 Feb 07, 2017: Haselmeier Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors 114
  • 6.61 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 114
  • 6.62 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 115
  • 6.63 Feb 01, 2017: West Introduces LyoSeal Instant Sealing Solution and NovaGuard SA Pro Safety System at Pharmapack Europe 116
  • 6.64 Feb 01, 2017: CONMED Announces Fourth Quarter and Fiscal Year 2016 Financial Results 117
  • 6.65 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 119
  • 6.66 Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report 120
  • 6.67 Jan 31, 2017: Terumo Opens a Branch in Yangon 121
  • 6.68 Jan 25, 2017: Vetter Starts Operations in Its Center for Visual Inspection and Logistics 121
  • 6.69 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 122
  • 6.70 Jan 12, 2017: Gerresheimer introduces metal-free syringe 122
  • 6.71 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 123
  • 6.72 Jan 12, 2017: Mikkel Danvold appointed new CEO of HTL-STREFA 124
  • 6.73 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 124
  • 6.74 Jan 10, 2017: Pyng Medical Reports Fiscal 2016 Financial Results 125
  • 6.75 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 126
  • 6.76 Jan 03, 2017: Nurse Assist Recalls Normal Saline Flush IV Syringes Due to Possible Burkholderia Cepacia Bloodstream Infections 126
  • 6.77 Dec 30, 2016: Medline Makes it Easier for Patients to Receive Critical Supplies through New Patient Home Direct Deal with ViaQuest 127
  • 6.78 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ 128
  • 6.79 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 128
  • 6.80 Dec 13, 2016: Vetter's Skokie site successfully manufactures batches on new clinical syringe filling line 129
  • 6.81 Dec 13, 2016: TUV Certification for the Bengaluru Facility 130
  • 6.82 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 130
  • 6.83 Dec 12, 2016: Skin patch with microneedles proves effective alternative to injections 131
  • 6.84 Dec 07, 2016: Medline Invests $20 Million in Flush Manufacturing Facilities Expansion 131
  • 6.85 Dec 07, 2016: Medline Invests $20 Million in Flush Manufacturing Facilities Expansion 132
  • 6.86 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion 132
  • 6.87 Nov 29, 2016: West Announces Expanded Contract Manufacturing Capabilities in Ireland 133
  • 6.88 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 134
  • 6.89 Nov 16, 2016: ITL BioMedical Announces Early Sales of Recently Launched New Product DonorCare Needle Guard 2 137
  • 6.90 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 137
  • 6.91 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 138
  • 6.92 Nov 15, 2016: Interim Report Vigmed Holding January - September 2016 139
  • 6.93 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016 139
  • 6.94 Nov 08, 2016: ITL BioMedical Announces Global Launch of DonorCare Needle Guard 2 141
  • 6.95 Nov 08, 2016: Extensive reorganisation at Haselmeier 141
  • 6.96 Nov 07, 2016: ITL Announces Significant Sales of its Recently Launched DonorCare Needle Guard 2 141
  • 6.97 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 142
  • 6.98 Nov 03, 2016: Vitrolife: Interim Report January-September 2016: Good Growth in All Market Regions 144
  • 6.99 Nov 02, 2016: Unilife Provides Business Update 144
  • 6.100 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 145
  • 6.101 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 146
  • 6.102 Oct 31, 2016: Suda: Appendix 4C For First Quarter Fy 2017 147
  • 6.103 Oct 28, 2016: Analytica: Appendix 4C - Quarterly Cash Flow Report 148
  • 6.104 Oct 27, 2016: West Announces Third Quarter 2016 Results 148
  • 6.105 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 150
  • 6.106 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 152
  • 6.107 Oct 24, 2016: ITL BioMedical Announces Global Launch of DonorCare Needle Guard 2 152
  • 6.108 Oct 24, 2016: Unilife Announces Filing of 2016 10-K 153
  • 6.109 Oct 24, 2016: Unilife Announces Fiscal Year 2016 Finanicial Results 155
  • 6.110 Oct 19, 2016: Hamilton founds Hamilton Ems and Hamilton Iberia 156
  • 6.111 Oct 17, 2016: West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices 157
  • 6.112 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 158
  • 6.113 Oct 13, 2016: Vigmed Signs Distribution Agreement For The Important Markets In The United Kingdom And Ireland 159
  • 6.114 Oct 11, 2016: Patheon Announces the Retirement of Stuart Grant 159
  • 6.115 Oct 10, 2016: NanoPass Technologies to Present Newly Released Data on Intradermal Flu Vaccination at the World Vaccine Congress (WVC) 2016 in Barcelona 159
  • 6.116 Oct 04, 2016: Nurse Assist Initiates Nationwide Voluntary Recall of All Unexpired Lots of I.V. Flush Syringes 160
  • 6.117 Sep 29, 2016: Unilife Provides Trading Update 160
  • 6.118 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 161
  • 6.119 Sep 23, 2016: Unilife Corporation Announces Receipt of Delinquency Letter from NASDAQ Relating to Fiscal 2016 Form 10-K 161
  • 6.120 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 162
  • 6.121 Sep 12, 2016: West Elects New Director and Announces Increase to Quarterly Dividend 163
  • 6.122 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 163
  • 6.123 Aug 31, 2016: Analytica Announces 2016 Full Year Results 164
  • 6.124 Aug 25, 2016: Programmable Syringe Pumps: FDA Safety Communication - Problems With Fluid Flow Continuity at Low Infusion Rates 165
  • 6.125 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 165
  • 6.126 Aug 25, 2016: Interim Report Vigmed Holding January - June 2016 168
  • 6.127 Aug 23, 2016: Pyng Medical Reports Third Quarter Fiscal 2016 Results 169
  • 6.128 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016 169

7 Appendix 172

  • 7.1 Methodology 172
  • 7.2 About GlobalData 175
  • 7.3 Contact Us 175
  • 7.4 Disclaimer 175

List of Tables

1.1 List of Tables

  • Table 1: Syringes and Needles - Pipeline Products by Stage of Development 11
  • Table 2: Syringes and Needles - Pipeline Products by Segment 12
  • Table 3: Syringes and Needles - Pipeline Products by Territory 13
  • Table 4: Syringes and Needles - Pipeline Products by Regulatory Path 14
  • Table 5: Syringes and Needles - Pipeline Products by Estimated Approval Date 15
  • Table 6: Syringes and Needles Companies - Pipeline Products by Stage of Development 16
  • Table 7: Syringes and Needles - Pipeline Products by Stage of Development 18
  • Table 8: ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 9: Lyophilized Dual Chamber Prefillable Syringe - Product Status 20
  • Table 10: Lyophilized Dual Chamber Prefillable Syringe - Product Description 20
  • Table 11: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 12: ENFit Enteral Syringe - Product Status 21
  • Table 13: ENFit Enteral Syringe - Product Description 21
  • Table 14: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 15: BD Cathena - Product Status 22
  • Table 16: BD Cathena - Product Description 23
  • Table 17: BD Hylok - Product Status 23
  • Table 18: BD Hylok - Product Description 23
  • Table 19: BD Posiflush Heparin Lock Flush Syringe - Product Status 23
  • Table 20: BD Posiflush Heparin Lock Flush Syringe - Product Description 24
  • Table 21: BD Sterifill Advance - Product Status 24
  • Table 22: BD Sterifill Advance - Product Description 24
  • Table 23: BD UltraSafe Plus Line Extention - Product Status 25
  • Table 24: BD UltraSafe Plus Line Extention - Product Description 25
  • Table 25: Smart Pen Needle - Product Status 25
  • Table 26: Smart Pen Needle - Product Description 25
  • Table 27: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 28: Blood Specimen Collection Syringe - Product Status 26
  • Table 29: Blood Specimen Collection Syringe - Product Description 26
  • Table 30: Pre-Filled Syringe With Flush - Product Status 27
  • Table 31: Pre-Filled Syringe With Flush - Product Description 27
  • Table 32: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 33: Max-200 - Product Status 28
  • Table 34: Max-200 - Product Description 28
  • Table 35: Excelsior Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 36: ZR Flush Syringe - Product Status 29
  • Table 37: ZR Flush Syringe - Product Description 29
  • Table 38: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 39: Restylane Syringe - Product Status 30
  • Table 40: Restylane Syringe - Product Description 30
  • Table 41: Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 42: Gx RTF ClearJect Needle Syringe - Product Status 31
  • Table 43: Gx RTF ClearJect Needle Syringe - Product Description 32
  • Table 44: Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 45: Dual Chamber Safety Prefillable Syringe - Product Status 33
  • Table 46: Dual Chamber Safety Prefillable Syringe - Product Description 33
  • Table 47: Safety Butterfly Needle - Product Status 34
  • Table 48: Safety Butterfly Needle - Product Description 34
  • Table 49: Single Chamber Safety Prefillable Syringe - Product Status 34
  • Table 50: Single Chamber Safety Prefillable Syringe - Product Description 34
  • Table 51: iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 52: iScience Smart Needle - Product Status 35
  • Table 53: iScience Smart Needle - Product Description 35
  • Table 54: Medigard Limited Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 55: Manual Retractable Syringe, 3ml - Product Status 36
  • Table 56: Manual Retractable Syringe, 3ml - Product Description 36
  • Table 57: Manual Retractable Syringe, 5ml - Product Status 37
  • Table 58: Manual Retractable Syringe, 5ml - Product Description 37
  • Table 59: Pre-Filled Auto Retract Syringe - Product Status 37
  • Table 60: Pre-Filled Auto Retract Syringe - Product Description 38
  • Table 61: Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 62: Self Retracting Cannula - Product Status 39
  • Table 63: Self Retracting Cannula - Product Description 39
  • Table 64: Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 65: UniSafe - Product Status 40
  • Table 66: UniSafe - Product Description 40
  • Table 67: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 68: Safety Dental Syringe - Product Status 41
  • Table 69: Safety Dental Syringe - Product Description 41
  • Table 70: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 71: Syringe - Product Status 42
  • Table 72: Syringe - Product Description 42
  • Table 73: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 74: Jersey Safety Syringe - Product Status 43
  • Table 75: Jersey Safety Syringe - Product Description 43
  • Table 76: Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 77: SYRINDICARE Syringe - Product Status 44
  • Table 78: SYRINDICARE Syringe - Product Description 44
  • Table 79: Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 80: DuoDraw Transfer and Injection Device - Product Status 45
  • Table 81: DuoDraw Transfer and Injection Device - Product Description 45
  • Table 82: PolyDermic Plastic Hypodermic Needle - Product Status 46
  • Table 83: PolyDermic Plastic Hypodermic Needle - Product Description 46
  • Table 84: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 85: PLAJEX With Tapered Needle - Product Status 47
  • Table 86: PLAJEX With Tapered Needle - Product Description 47
  • Table 87: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 88: EZMix Engage - Product Status 48
  • Table 89: EZMix Engage - Product Description 49
  • Table 90: EZMix Genesis - Product Status 49
  • Table 91: EZMix Genesis - Product Description 49
  • Table 92: EZMix Prodigy - Product Status 50
  • Table 93: EZMix Prodigy - Product Description 50
  • Table 94: Ocu-ject - Product Status 50
  • Table 95: Ocu-ject - Product Description 51
  • Table 96: Unifill Finesse - Product Status 51
  • Table 97: Unifill Finesse - Product Description 51
  • Table 98: Unifill Select - Product Status 52
  • Table 99: Unifill Select - Product Description 52
  • Table 100: United Medical Innovations Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 101: Simple Push Syringe - Product Status 53
  • Table 102: Simple Push Syringe - Product Description 53
  • Table 103: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 104: Microfabricated Microneedle - Product Status 54
  • Table 105: Microfabricated Microneedle - Product Description 54
  • Table 106: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 107: Ergonomic Syringe - Product Status 55
  • Table 108: Ergonomic Syringe - Product Description 55
  • Table 109: University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 110: Syringe Needle Injection System - Product Status 56
  • Table 111: Syringe Needle Injection System - Product Description 56
  • Table 112: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 113: MicroNeedles - Product Status 57
  • Table 114: MicroNeedles - Product Description 57
  • Table 115: Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 116: Dual-Vial Injection Device - Product Status 58
  • Table 117: Dual-Vial Injection Device - Product Description 58
  • Table 118: Glossary 174

List of Figures

1.2 List of Figures

  • Figure 1: Syringes and Needles - Pipeline Products by Stage of Development 11
  • Figure 2: Syringes and Needles - Pipeline Products by Segment 12
  • Figure 3: Syringes and Needles - Pipeline Products by Territory 13
  • Figure 4: Syringes and Needles - Pipeline Products by Regulatory Path 14
  • Figure 5: Syringes and Needles - Pipeline Products by Estimated Approval Date 15
Back to Top